FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
Emergent novel SARS-CoV-2 is responsible for the current pandemic outbreak of severe acute respiratory syndrome with high mortality among the symptomatic population worldwide. Given the absence of a current vaccine or specific antiviral treatment, it is urgent to search for FDA-approved drugs that c...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | , , |
| 格式: | Artículo |
| 语言: | English |
| 出版: |
2020
|
| 主题: | |
| 在线阅读: | https://doi.org/10.1080/07391102.2020.1764393 https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1764393?needAccess=true |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
